TULP2 Antibody

What is TULP2 and what is its biological significance?

TULP2 is a member of the Tubby-like protein family that functions as an RNA-binding protein despite lacking canonical RNA-binding domains. It contains two conserved domains: Tub (Tubby) and DUF1168 . TULP2 plays critical roles in:

• Post-transcriptional regulation during spermatogenesis

• Spermatid differentiation and sperm tail formation

• Energy metabolism in sperm cells

• Regulation of specific transcripts related to cytoskeleton, apoptosis, and RNA metabolism

Notably, TULP2 expression is highly specific to testicular tissue in humans, suggesting specialized functions in male reproduction . Unlike its family members that function in retinal cells and metabolic regulation, TULP2's primary function appears concentrated in reproductive biology.

TULP2 antibodies have been validated for multiple experimental applications:

• Western blotting: Detection of endogenous TULP2 protein in tissue lysates, particularly from testicular tissue

• Immunofluorescence (IF): Visualization of TULP2 expression and localization in round spermatids and elongating spermatids

• Immunoprecipitation (IP): Isolation of TULP2 protein complexes for interaction studies

• ELISA: Quantitative measurement of TULP2 protein levels

• Immunohistochemistry (IHC): Examination of TULP2 expression patterns in tissue sections

The F-1 monoclonal antibody is additionally available in various conjugated forms, including agarose, HRP, PE, FITC, and Alexa Fluor conjugates, expanding its versatility for different experimental approaches .

What are the optimal protocols for Western blot detection of TULP2?

For optimal Western blot detection of TULP2, researchers should consider the following protocol:

• Sample preparation:

  • Extract proteins from testicular tissue using RIPA lysis buffer containing protease inhibitor cocktail

  • For mouse samples, using ~20-30 μg of total protein per lane is recommended

• Electrophoresis and transfer:

  • Separate proteins using 10-12% SDS-PAGE gels

  • Transfer to nitrocellulose membranes using standard protocols

• Antibody incubation:

  • Block membranes with 5% non-fat milk or BSA

  • Primary antibody dilutions:

    • Custom polyclonal antibody: 1:5000

    • Commercial monoclonal antibody (F-1): 1:500-1:1000

  • Incubate overnight at 4°C

  • Secondary antibody: HRP-conjugated at 1:5000-1:10000 dilution

• Detection:

  • Enhanced chemiluminescence (ECL) detection

  • ACTIN (1:8000) is recommended as loading control

Researchers should be aware that TULP2 protein has a molecular weight of approximately 58 kDa, and expression is primarily detected in testicular tissue samples but not in most somatic tissues .

How should immunofluorescence be performed with TULP2 antibodies?

Optimal immunofluorescence staining for TULP2 requires specific tissue preparation and antibody handling:

• Tissue processing:

  • Fix testicular tissue in 4% paraformaldehyde

  • Embed in paraffin or prepare cryosections (8-10 μm thickness)

  • For paraffin sections, perform antigen retrieval (citrate buffer, pH 6.0)

• Staining protocol:

  • Block sections with 1% bovine serum albumin

  • Incubate with primary antibody:

    • Polyclonal TULP2 antibody at 1:100 dilution

    • Commercial antibodies at manufacturer-recommended dilutions

  • Incubate overnight at 4°C

  • Use fluorophore-conjugated secondary antibody (e.g., 488-conjugated) at 1:500 dilution

  • Counterstain nuclei with DAPI

• Controls:

  • Include rabbit IgG as negative control at equivalent concentration

  • Include TULP2 knockout tissue for specificity verification where available

• Imaging:

  • Use confocal microscopy for optimal resolution

  • Focus on seminiferous tubules to observe round spermatids and elongating spermatids

TULP2 staining should show specific localization in round spermatids and elongating spermatids, with minimal background in other cell types .

What are the recommended methods for validating TULP2 antibody specificity?

Validating TULP2 antibody specificity is critical for reliable experimental results. Recommended methods include:

• Western blot analysis:

  • Compare detection in wild-type vs. TULP2 knockout testicular tissue

  • Test detection in multiple species if cross-reactivity is claimed

  • Assess molecular weight specificity (TULP2: ~58 kDa)

• Immunoprecipitation validation:

  • Perform IP followed by mass spectrometry to confirm target protein identity

  • Compare with IgG control immunoprecipitation

• Recombinant protein controls:

  • Test antibody against purified recombinant TULP2 protein

  • Perform peptide competition assays to confirm epitope specificity

• Immunostaining controls:

  • Compare staining pattern in wild-type vs. knockout tissue

  • Assess tissue-specific expression pattern (primarily testis)

  • Evaluate subcellular localization consistency across methods

• ELISA titer determination:

  • Determine antibody titer (e.g., polyclonal antibodies should demonstrate titers of approximately 1:1,000,000)

Researchers should document all validation steps and include appropriate controls in publications to demonstrate antibody specificity and reliability.

How can TULP2 antibodies be used to study male infertility mechanisms?

TULP2 antibodies offer powerful tools for investigating male infertility mechanisms:

• Clinical sample analysis:

  • Immunohistochemical analysis of testicular biopsies from infertile patients

  • Comparison of TULP2 expression patterns between fertile and infertile individuals

  • Correlation of TULP2 expression levels with specific sperm parameters

• Functional studies in model systems:

  • Immunolocalization of TULP2 in wild-type and infertile mouse models

  • Co-localization with known fertility factors during spermatogenesis

  • Examination of TULP2 expression in specific subtypes of infertility (e.g., asthenozoospermia)

• Molecular mechanism investigation:

  • Immunoprecipitation of TULP2-containing RNP complexes followed by RNA sequencing

  • Identification of TULP2-bound transcripts relevant to sperm function

  • Analysis of TULP2 post-translational modifications in normal vs. pathological conditions

• Mutation analysis workflow:

  • Screening for TULP2 mutations in infertile patients (e.g., c.832C > T [p.Arg278Trp], c.871A > G [p.Thr291Ala], c.829C > A [p.Leu277Met])

  • Functional characterization of mutant TULP2 proteins using antibodies

  • Assessment of mutant TULP2 stability, localization, and RNA-binding capacity

TULP2 research is particularly relevant for patients with oligo-astheno-teratozoospermia, as TULP2 defects affect sperm count, motility, and morphology .

What approaches are effective for studying TULP2's role as an RNA-binding protein?

Despite lacking canonical RNA-binding domains, TULP2 functions as an RNA-binding protein. Effective approaches to study this function include:

• RNA immunoprecipitation (RIP):

  • Immunoprecipitate TULP2 using validated antibodies

  • Extract and analyze co-precipitated RNAs by sequencing or qPCR

  • Compare RIP results between wild-type and mutant TULP2 proteins

• CLIP-seq approaches:

  • Perform cross-linking immunoprecipitation followed by sequencing

  • Map TULP2 binding sites on target RNAs with nucleotide resolution

  • Identify RNA motifs recognized by TULP2

• In vitro RNA binding assays:

  • Express and purify recombinant TULP2 protein

  • Perform electrophoretic mobility shift assays (EMSA)

  • Utilize filter binding assays with labeled RNA probes

• Functional validation:

  • Examine expression levels of target transcripts in TULP2 knockout models

  • Perform luciferase reporter assays with TULP2-binding elements

  • Assess translational efficiency of TULP2 target mRNAs

• Domain mapping:

  • Create deletion constructs of TULP2 to identify RNA-binding regions

  • Generate antibodies against specific domains to block RNA binding

  • Investigate the role of Tub and DUF1168 domains in RNA interaction

Understanding TULP2's RNA-binding mechanisms will add to our knowledge of unconventional RBPs in reproductive biology.

How can researchers investigate potential protein interaction partners of TULP2?

To investigate TULP2 protein interactions:

• Co-immunoprecipitation and mass spectrometry:

  • Immunoprecipitate TULP2 from testicular tissue or transfected cells

  • Identify co-precipitated proteins by mass spectrometry

  • Validate interactions by reverse co-IP with antibodies against identified partners

• Proximity labeling approaches:

  • Create TULP2 fusion proteins with BioID or APEX tags

  • Identify proximal proteins through biotinylation and streptavidin pulldown

  • Compare interactome in different spermatogenic stages

• Yeast two-hybrid screening:

  • Use TULP2 as bait to screen testis cDNA libraries

  • Validate interactions in mammalian systems using co-IP

  • Map interaction domains through deletion constructs

• Immunofluorescence co-localization:

  • Perform dual immunofluorescence with TULP2 and potential partners

  • Analyze co-localization through confocal microscopy

  • Quantify spatial correlation using appropriate software

Previous studies have identified the CCT complex (particularly CCT8) as a potential TULP2 interactor that may facilitate proper TULP2 folding and function in spermiogenesis . This approach can uncover regulatory mechanisms controlling TULP2 activity during spermatogenesis.

How to address non-specific binding in TULP2 antibody experiments?

Non-specific binding is a common challenge when working with TULP2 antibodies. Researchers can implement these solutions:

• Antibody selection and validation:

  • Use full-length protein-derived antibodies rather than domain-specific ones

  • Research indicates that antibodies generated against TULP2-C domain showed poor specificity compared to full-length TULP2 antibodies

  • Validate antibody specificity using TULP2 knockout tissue when available

• Western blot optimization:

  • Increase blocking time/concentration (5% BSA or milk for 1-2 hours)

  • Optimize primary antibody dilution (typically 1:1000-1:5000)

  • Increase washing duration and number of washes

  • Use gradient SDS-PAGE to better resolve TULP2 from similar-sized proteins

• Immunofluorescence improvements:

  • Include additional blocking steps with serum from secondary antibody species

  • Reduce primary antibody concentration

  • Use monoclonal antibodies for higher specificity

  • Pre-adsorb antibodies with acetone powder from non-target tissues

• Cross-reactivity testing:

  • Test antibodies against other TULP family members (TULP1, TULP3)

  • Include peptide competition controls to confirm signal specificity

  • Use IgG controls at equivalent concentrations to primary antibody

What are optimal conditions for TULP2 protein extraction and detection?

Effective TULP2 protein extraction and detection requires specific considerations:

• Tissue selection:

  • TULP2 is predominantly expressed in testicular tissue

  • Expression is specifically localized to round spermatids and elongating spermatids

  • Developmental timing is critical - adult testes show higher expression

• Extraction buffer composition:

  • RIPA buffer with protease inhibitor cocktail is effective

  • Buffer composition: 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS

  • Include protease inhibitors (e.g., from Bimake, B14001)

• Lysis conditions:

  • Maintain samples at 4°C throughout extraction

  • Use mechanical disruption (homogenization) followed by brief sonication

  • Clarify lysates by centrifugation at ≥12,000g for 15 minutes

• Storage considerations:

  • Aliquot protein extracts to avoid freeze-thaw cycles

  • Store at -80°C for long-term stability

  • Include reducing agents (DTT or β-mercaptoethanol) in sample buffer

• Detection optimization:

  • Expected molecular weight: ~58 kDa

  • Use 10-12% polyacrylamide gels for optimal resolution

  • Consider gradient gels for better separation from similar weight proteins

How can researchers differentiate between TULP family members in experiments?

Distinguishing between TULP family members requires careful experimental design:

• Antibody selection:

  • Choose antibodies raised against unique regions of TULP2

  • Avoid antibodies targeting the conserved Tub domain shared among family members

  • Validate specificity against recombinant proteins of all TULP family members

• Expression pattern analysis:

  • TULP2: Predominantly expressed in testis (spermatids)

  • TULP1: Specifically expressed in retina

  • TULP3: Broader tissue expression pattern

  • TUB: Inner segments of photoreceptor cells and metabolic tissues

• Molecular verification:

  • Use RT-PCR with isoform-specific primers

  • Sequence verification of immunoprecipitated proteins

  • Western blot using isoform-specific antibodies with recombinant protein controls

• Functional distinction approaches:

  • TULP2: Focus on male fertility parameters and RNA metabolism

  • TULP1: Associated with retinitis pigmentosa

  • TUB: Linked to obesity and sensory defects

• Knockout model comparisons:

  • Compare phenotypes between different TULP family knockouts

  • TULP2 knockout: Male infertility without metabolic phenotypes

  • TUB mutants: Obesity, retinal degeneration, and hearing loss

How might TULP2 antibodies contribute to clinical diagnostics in reproductive medicine?

TULP2 antibodies hold significant potential for clinical applications in reproductive medicine:

• Diagnostic biomarker development:

  • Development of immunohistochemical assays for testicular biopsies

  • Correlation of TULP2 expression patterns with specific infertility types

  • Potential for seminal plasma TULP2 detection as non-invasive biomarker

• Genetic screening correlation:

  • Immunodetection of TULP2 protein in patients with identified genetic variants

  • Functional assessment of TULP2 mutations identified in infertile patients

  • TULP2 mutations have been identified in heterozygous states in infertile men (c.832C > T [p.Arg278Trp], c.871A > G [p.Thr291Ala], c.829C > A [p.Leu277Met])

• Therapeutic target assessment:

  • Monitoring TULP2 expression/function in response to fertility treatments

  • Screening for compounds that modulate TULP2 activity

  • Development of targeted therapies for TULP2-deficient patients

• Personalized medicine applications:

  • TULP2 status as a predictor of assisted reproductive technology outcomes

  • Stratification of infertility patients based on TULP2-related parameters

  • Tailored treatment approaches for patients with TULP2 abnormalities

What emerging techniques might enhance TULP2 antibody-based research?

Several emerging technologies could advance TULP2 antibody applications:

• Single-cell antibody-based techniques:

  • Single-cell Western blotting to analyze TULP2 expression heterogeneity

  • Mass cytometry (CyTOF) with metal-conjugated TULP2 antibodies

  • Spatial transcriptomics combined with TULP2 immunodetection

• Live-cell imaging approaches:

  • Development of cell-permeable TULP2 antibody fragments

  • Fluorescent nanobodies against TULP2 for live imaging

  • CRISPR-based tagging of endogenous TULP2 for dynamic studies

• High-throughput screening applications:

  • Antibody arrays for TULP2 interaction partner screening

  • Automated immunofluorescence screening of TULP2 modulators

  • Combinatorial assessment of TULP2 with other fertility factors

• Integrative multi-omics approaches:

  • Correlation of TULP2 protein levels with transcriptome and metabolome data

  • Proteogenomic analysis of TULP2 pathways in spermatogenesis

  • Systems biology modeling of TULP2 networks using antibody-derived data